Short Interest in BioNxt Solutions Inc. (OTCMKTS:BNXTF) Grows By 3,206.3%

BioNxt Solutions Inc. (OTCMKTS:BNXTF) was the recipient of a large increase in short interest in the month of November. As of November 30th, there was short interest totalling 52,900 shares, an increase of 3,206.3% from the November 15th total of 1,600 shares. Based on an average daily volume of 52,700 shares, the short-interest ratio is presently 1.0 days.

BioNxt Solutions Stock Performance

OTCMKTS BNXTF traded down $0.02 on Wednesday, reaching $0.21. The company had a trading volume of 770 shares, compared to its average volume of 4,853. The firm has a market capitalization of $23.50 million, a price-to-earnings ratio of -5.18 and a beta of 0.84. BioNxt Solutions has a 1-year low of $0.11 and a 1-year high of $0.57. The company’s fifty day moving average is $0.19 and its 200-day moving average is $0.20.

BioNxt Solutions Company Profile

BioNxt Solutions Inc engages in generation drug formulations and delivery system in Korea, Austria, Germany, and Switzerland. The company provides drug delivery methods, such as transdermal patches and oral dissolvable films designed for delivery of neurological medications. It offers point-of-care diagnostic, including covid-19 PCR diagnostic kit, a covid rapid test; peri-implantitis Oral Biosensor, allows early detection of infection associated with dental implants; and H1N1 (Swine Flu) and H5N1 (Avian Flu) oral biosensors for early detection of highly pathogenic influenza a strains.